MIRA
INFORM REPORT
|
Report Date : |
23.01.2012 |
IDENTIFICATION DETAILS
|
Name : |
TRIVITRON HEALTHCARE PRIVATE LIMITED |
|
|
|
|
Formerly Known As : |
TRIVITRON DIAGNOSTICS PRIVATE LIMITED |
|
|
|
|
Registered Office : |
Trivitron Sapthagiri Bhawan, No. 15, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.03.2011 |
|
|
|
|
Date of Incorporation : |
18.05.1998 |
|
|
|
|
Com. Reg. No.: |
18-040515 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs. 8.103 Millions |
|
|
|
|
CIN No.: [Company
Identification No.] |
U85110TN1998PTC040515 |
|
|
|
|
TAN No.: [Tax
Deduction & Collection Account No.] |
CHET07271F /
CHET07756A |
|
|
|
|
PAN No.: [Permanent
Account No.] |
AAACT9378H |
|
|
|
|
Legal Form : |
Private Limited
Liability Company |
|
|
|
|
Line of Business : |
Manufacturers of
Diagnostic Products |
|
|
|
|
No. of Employees
: |
100 (Approximately) |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba (53) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Maximum Credit Limit : |
USD 2200000 |
|
|
|
|
Status : |
Good |
|
|
|
|
Payment Behaviour : |
Regular |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a well established company having fine track. Financial position
of the company appears to be sound. Trade relations are reported as fair.
Business is active. Payments are reported to be regular and as per
commitments. The company can be considered good for normal business dealings at
usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – September 30, 2011
|
Country Name |
Previous Rating (30.06.2011) |
Current Rating (30.09.2011) |
|
India |
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
INFORMATION PARTED BY
|
Name : |
Ms. Anandi |
|
Designation : |
Accounts Department |
|
Contact No.: |
91-44-24985050 |
|
Date : |
21.01.2012 |
LOCATIONS
|
Registered Office/Factory: |
Trivitron Sapthagiri Bhawan, No. 15, |
|
Tel. No.: |
91-44-24985050 /
28522216 / 28594817/ 24985151/ 5656 |
|
Fax No.: |
91-44-24985757 /
28548997 |
|
E-Mail : |
|
|
Website: |
|
|
|
|
|
Corporate Office : |
Trivitron Group of Companies. 15, |
|
Tel. No.: |
91 - 44 - 2498 5050 (6 lines) |
|
Fax No.: |
91 - 44 - 2498 5757 / 2467 2782 |
|
E-Mail : |
|
|
|
|
|
Regional Offices: |
CHENNAI (Renal Care) NEW DELHI MUMBAI MUMBAI ( Diagnostics ) KOLKATA
|
|
|
|
|
Overseas Offices: |
SRI
LANKA DUBAI |
|
|
|
|
Branches : |
AHMEDABAD
PUNE
JAIPUR
|
DIRECTORS
As on :15.09.2011
|
Name : |
Dr. G. S. K. Velu
|
|
Designation : |
Managing Director
|
|
Address : |
No. 25 (Old No.
13), 1st |
|
Date of Birth/Age : |
30.06.1967 |
|
Date of Appointment : |
21.01.1999 |
|
Din No.: |
00894980 |
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U33112TN1997PTC037396 |
TRIVITRON
MEDICAL SYSTEMS PRIVATE LIMITED |
Director |
27/01/1997 |
27/01/1997 |
- |
Active |
NO |
|
2 |
U85110TN1998PTC040515 |
TRIVITRON
HEALTHCARE PRIVATE LIMITED |
Managing
director |
18/05/1998 |
18/05/1998 |
- |
Active |
NO |
|
3 |
U74140TN1999PTC043339 |
TRIVITRON
MEDICAL TECHNOLOGIES PRIVATE LIMITED |
Director |
12/10/1999 |
12/10/1999 |
- |
Active |
NO |
|
4 |
U85195TN2000PTC043978 |
TRIPOLI
PATH LAB PRIVATE LIMITED |
Director |
21/01/2000 |
21/01/2000 |
- |
Amalgamated |
NO |
|
5 |
U29297TN2001PTC047581 |
TRIVITRON
DENTAL TECHNOLOGIES PRIVATE LIMITED |
Director |
13/08/2001 |
13/08/2001 |
- |
Active |
NO |
|
6 |
U85195KL1983PTC003809 |
SUDHARMA
METROPOLIS HEALTH SERVICES PRIVATE LIMITED |
Director |
30/11/2002 |
30/11/2002 |
- |
Active |
NO |
|
7 |
U85195TN2000PTC046354 |
LISTER
METROPOLIS LABORATORY AND RESEARCH CENTRE PRIVATE LIMITED |
Whole-time
director |
18/01/2003 |
18/01/2003 |
- |
Amalgamated |
NO |
|
8 |
U85195MH2003PLC141177 |
METROPOLIS
HEALTH SERVICES ( |
Managing
director |
1/1/2008 |
4/7/2003 |
- |
Amalgamated |
NO |
|
9 |
U85110MH2003PTC141412 |
METRO
HOME HEALTH SERVICES PRIVATE LIMITED |
Director |
21/07/2003 |
21/07/2003 |
- |
Amalgamated |
NO |
|
10 |
U29297TN2003PTC051492 |
BIOSYSTEMS
DIAGNOSTICS PRIVATE LIMITED |
Director |
18/02/2004 |
18/02/2004 |
- |
Active |
NO |
|
11 |
U85110DL2004PTC128931 |
DIWAN
CHAND METROPOLIS DIAGNOSTICE SERVICES PRIVATE LIMITED |
Director |
9/9/2004 |
9/9/2004 |
- |
Amalgamated |
NO |
|
12 |
U73100MH2000PLC192798 |
METROPOLIS
HEALTHCARE LIMITED |
Whole-time
director |
2/7/2010 |
17/08/2005 |
- |
Active |
NO |
|
13 |
U85195MH1998PTC141735 |
GOLWILKAR
METROPOLIS HEALTH SERVICES ( |
Director |
15/10/2005 |
15/10/2005 |
- |
Active |
NO |
|
14 |
U84110GJ1997PTC032115 |
SANKET
METROPOLIS HEALTH SERVICES ( |
Director |
2/4/2007 |
2/4/2007 |
- |
Active |
NO |
|
15 |
U33112PN2005PTC021225 |
VISION
MEDICAID EQUIPMENTS PRIVATE LIMITED |
Director |
29/09/2007 |
25/08/2007 |
- |
Active |
NO |
|
16 |
U33111TN2007PTC064858 |
ALOKA
TRIVITRON MEDICAL TECHNOLOGIES PRIVATE LIMITED |
Director |
24/09/2007 |
24/09/2007 |
- |
Active |
NO |
|
17 |
U85110TN2007PTC065138 |
HEXEL
HEALTHCARE CONSULTING ( |
Director |
24/10/2007 |
24/10/2007 |
- |
Active |
NO |
|
18 |
U85195GJ2008PTC052594 |
DESAI
METROPOLIS HEALTH SERVICES PRIVATE LIMITED |
Director |
8/1/2008 |
8/1/2008 |
- |
Active |
NO |
|
19 |
U85110KA2005PTC035919 |
R.V.METROPOLIS
DIAGNOSTIC & HEALTH CARE CENTER PRIVATE LIMITED |
Director |
25/09/2008 |
3/4/2008 |
- |
Active |
NO |
|
20 |
U85110TN2008PLC068161 |
|
Director |
12/6/2008 |
12/6/2008 |
- |
Active |
NO |
|
21 |
U29297TN2008PTC068229 |
JOHARI
TRIVITRON MEDICAL INNOVATIONS PRIVATE LIMITED |
Director |
16/06/2008 |
16/06/2008 |
- |
Active |
NO |
|
22 |
U85195TN2008PTC068998 |
ET TRIVITRON
MEDICAL SOLUTIONS PRIVATE LIMITED |
Director |
25/08/2008 |
25/08/2008 |
- |
Active |
NO |
|
23 |
U85100BR2008PTC013973 |
METROPOLIS
CLINICAL DIAGNOSTICS ( |
Director |
1/10/2008 |
1/10/2008 |
6/10/2010 |
Active |
|
|
24 |
U85110MH2001PTC217689 |
FINAL
DIAGNOSIS PRIVATE LIMITED |
Director |
3/9/2009 |
2/3/2009 |
- |
Active |
NO |
|
25 |
U85100MH2009PTC196736 |
PARAKH
CLINICAL LABORATORIES PRIVATE LIMITED |
Director |
29/10/2009 |
29/10/2009 |
- |
Active |
NO |
|
26 |
U85120TN2002PTC049414 |
ALLIANCE
DENTAL CARE PRIVATE LIMITED |
Director |
30/09/2010 |
18/03/2010 |
- |
Active |
NO |
|
27 |
U85110TN2010PTC075352 |
MEDFORT
HOSPITALS PRIVATE LIMITED |
Director |
15/04/2010 |
15/04/2010 |
- |
Active |
NO |
|
28 |
U85110DL2002PTC116372 |
SHARP
SIGHT LASER CENTRE PRIVATE LIMITED |
Director |
30/09/2010 |
7/6/2010 |
- |
Active |
NO |
|
29 |
U85110TN2010PTC078294 |
MEDFORT
DIABETIC CARE PRIVATE LIMITED |
Whole-time
director |
2/12/2010 |
2/12/2010 |
- |
Active |
NO |
|
30 |
U80101AP1995PTC022122 |
MAXIVISION
LASER CENTRE PRIVATE LIMITED |
Additional
director |
14/07/2011 |
14/07/2011 |
- |
Active |
NO |
|
31 |
U33111MH1974PLC017458 |
KIRAN
MEDICAL SYSTEMS LIMITED |
Additional
director |
5/8/2011 |
5/8/2011 |
- |
Active |
NO |
|
Name : |
Mrs. Subha K Velu
|
|
Designation : |
Director |
|
Address : |
No. 25 (Old No.
13), 1st |
|
Date of Birth/Age : |
25.10.1972 |
|
Date of Appointment : |
27.01.1997 |
|
Din No.: |
00180390 |
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U33112TN1997PTC037396 |
TRIVITRON
MEDICAL SYSTEMS PRIVATE LIMITED |
Director |
27/01/1997 |
27/01/1997 |
- |
Active |
NO |
|
2 |
U85110TN1998PTC040515 |
TRIVITRON
HEALTHCARE PRIVATE LIMITED |
Director |
5/1/1999 |
18/05/1998 |
- |
Active |
NO |
|
3 |
U74140TN1999PTC043339 |
TRIVITRON
MEDICAL TECHNOLOGIES PRIVATE LIMITED |
Director |
12/10/1999 |
12/10/1999 |
- |
Active |
NO |
|
4 |
U29297TN2001PTC047581 |
TRIVITRON
DENTAL TECHNOLOGIES PRIVATE LIMITED |
Director |
13/08/2001 |
13/08/2001 |
- |
Active |
NO |
|
5 |
U85195MH2003PLC141177 |
METROPOLIS
HEALTH SERVICES ( |
Director |
4/7/2003 |
4/7/2003 |
29/09/2007 |
Amalgamated |
NO |
|
6 |
U29297TN2003PTC051492 |
BIOSYSTEMS
DIAGNOSTICS PRIVATE LIMITED |
Director |
1/9/2003 |
1/9/2003 |
- |
Active |
NO |
|
7 |
U33112PN2005PTC021225 |
VISION
MEDICAID EQUIPMENTS PRIVATE LIMITED |
Director |
29/09/2007 |
25/08/2007 |
- |
Active |
NO |
|
8 |
U33111TN2007PTC064858 |
ALOKA
TRIVITRON MEDICAL TECHNOLOGIES PRIVATE LIMITED |
Director |
24/09/2007 |
24/09/2007 |
10/8/2011 |
Active |
NO |
|
9 |
U85110TN2007PTC065138 |
HEXEL
HEALTHCARE CONSULTING ( |
Director |
24/10/2007 |
24/10/2007 |
- |
Active |
NO |
|
10 |
U85110TN2008PLC068161 |
|
Director |
12/6/2008 |
12/6/2008 |
- |
Active |
NO |
|
11 |
U29297TN2008PTC068229 |
JOHARI
TRIVITRON MEDICAL INNOVATIONS PRIVATE LIMITED |
Director |
16/06/2008 |
16/06/2008 |
- |
Active |
NO |
|
12 |
U85195TN2008PTC068998 |
ET
TRIVITRON MEDICAL SOLUTIONS PRIVATE LIMITED |
Director |
25/08/2008 |
25/08/2008 |
- |
Active |
NO |
|
13 |
U85110TN2010PTC075352 |
MEDFORT
HOSPITALS PRIVATE LIMITED |
Director |
15/04/2010 |
15/04/2010 |
- |
Active |
NO |
|
14 |
U85110TN2010PTC078294 |
MEDFORT
DIABETIC CARE PRIVATE LIMITED |
Director |
2/12/2010 |
2/12/2010 |
- |
Active |
NO |
|
Name : |
Mr. Sameer D
Saral |
|
Designation : |
Director |
|
Address : |
C 3, Kosala No.
14, |
|
Date of Birth/Age : |
17.06.1963 |
|
Date of Appointment : |
27.01.1997 |
|
Din No.: |
00838100 |
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U85110TN1998PTC040515 |
TRIVITRON
HEALTHCARE PRIVATE LIMITED |
Director |
18/05/2007 |
18/05/1998 |
- |
Active |
NO |
|
2 |
U33111TN2007PTC064858 |
ALOKA
TRIVITRON MEDICAL TECHNOLOGIES PRIVATE LIMITED |
Director |
29/09/2010 |
18/07/2010 |
10/8/2011 |
Active |
NO |
|
Name : |
Mr. Chandrasekhar Kandasamy |
|
Designation : |
Director |
|
Address : |
Villa 17, phase I, palm Meadows, |
|
Date of Birth/Age : |
31.01.1967 |
|
Date of Appointment : |
31.10.2007 |
|
Din no.: |
00236761 |
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U67190KA2006PTC039109 |
EPLANET
ADVISORS PRIVATE LIMITED |
Director |
25/04/2006 |
25/04/2006 |
- |
Active |
NO |
|
2 |
U72300KA2003PTC033038 |
MANTHAN
SOFTWARE SERVICES PRIVATE LIMITED |
Nominee
director |
22/07/2010 |
20/03/2007 |
- |
Active |
NO |
|
3 |
U85110TN1998PTC040515 |
TRIVITRON
HEALTHCARE PRIVATE LIMITED |
Nominee
director |
31/10/2007 |
31/10/2007 |
- |
Active |
NO |
|
4 |
U33112TN1997PTC037396 |
TRIVITRON
MEDICAL SYSTEMS PRIVATE LIMITED |
Nominee
director |
31/10/2007 |
31/10/2007 |
15/12/2010 |
Active |
NO |
|
5 |
U74140TN1999PTC043339 |
TRIVITRON
MEDICAL TECHNOLOGIES PRIVATE LIMITED |
Nominee
director |
31/10/2007 |
31/10/2007 |
15/12/2010 |
Active |
NO |
|
6 |
U29297TN2003PTC051492 |
BIOSYSTEMS
DIAGNOSTICS PRIVATE LIMITED |
Nominee
director |
31/10/2007 |
31/10/2007 |
16/09/2008 |
Active |
NO |
|
7 |
U24117TN1994PTC029550 |
SREE
RAMCIDES CHEMICALS PRIVATE LIMITED |
Director |
29/07/2009 |
20/11/2008 |
- |
Active |
NO |
|
8 |
U63090MH1997PLC108197 |
CONTINENTAL
WAREHOUSING CORPORATION (NHAVA SEVA) LIMITED |
Nominee
director |
30/07/2009 |
30/07/2009 |
11/4/2011 |
Active |
NO |
|
9 |
U74900TN2009PTC071996 |
DELEX
CARGO INDIA PRIVATE LIMITED |
Director |
11/11/2010 |
25/09/2009 |
11/4/2011 |
Active |
NO |
|
10 |
U85110DL2002PTC116372 |
SHARP
SIGHT LASER CENTRE PRIVATE LIMITED |
Director |
30/09/2010 |
5/7/2010 |
1/2/2011 |
Active |
NO |
|
11 |
U85110TN2010PTC075352 |
MEDFORT
HOSPITALS PRIVATE LIMITED |
Director |
28/09/2011 |
12/7/2010 |
- |
Active |
NO |
|
12 |
U40101TN2005PTC058237 |
AURO
MIRA ENERGY COMPANY PRIVATE LIMITED |
Nominee
director |
28/09/2010 |
28/09/2010 |
- |
Active |
NO |
|
13 |
U80301KA2008PTC045922 |
ACE
CREATIVE LEARNING PRIVATE LIMITED |
Director |
1/12/2010 |
1/12/2010 |
- |
Active |
NO |
|
14 |
U72400TN2004PTC054226 |
NEWGEN
KNOWLEDGE WORKS PRIVATE LIMITED |
Additional
director |
30/05/2011 |
30/05/2011 |
- |
Active |
NO |
|
15 |
U80101AP1995PTC022122 |
MAXIVISION
LASER CENTRE PRIVATE LIMITED |
Additional
director |
14/07/2011 |
14/07/2011 |
- |
Active |
NO |
|
Name : |
Mr. James Frederick Savage |
|
Designation : |
Director |
|
Address : |
8A Block 18, |
|
Date of Birth/Age : |
18.04.1969 |
|
Date of Appointment : |
31.10.2007 |
|
Din no.: |
01505485 |
|
S.No. |
CIN |
Name
of the Company |
Current
designation of the director |
Date
of appointment at current designation |
Original
date of appointment |
Date
of cessation |
Company
Status |
Defaulting
status |
|
1 |
U74140MH2006FTC166361 |
HEADLAND
CAPITAL PARTNERS ( |
Director |
3/9/2007 |
3/7/2007 |
31/12/2008 |
Active |
NO |
|
2 |
U85110TN1998PTC040515 |
TRIVITRON
HEALTHCARE PRIVATE LIMITED |
Nominee
director |
31/10/2007 |
31/10/2007 |
- |
Active |
NO |
|
3 |
U33112TN1997PTC037396 |
TRIVITRON
MEDICAL SYSTEMS PRIVATE LIMITED |
Nominee
director |
31/10/2007 |
31/10/2007 |
- |
Active |
NO |
|
4 |
U29297TN2001PTC047581 |
TRIVITRON
DENTAL TECHNOLOGIES PRIVATE LIMITED |
Nominee
director |
31/10/2007 |
31/10/2007 |
- |
Active |
NO |
|
5 |
U72200DL1992PLC049074 |
NEWGEN
SOFTWARE TECHNOLOGIES LIMITED |
Director |
30/09/2008 |
13/12/2007 |
- |
Active |
NO |
|
6 |
U72900MH2006PLC162656 |
FINANCIAL
INCLUSION NETWORK AND OPERATIONS LIMITED |
Nominee
director |
3/12/2009 |
3/12/2009 |
- |
Active |
NO |
|
7 |
U32200MH2000PLC126562 |
AVITEL
POST STUDIOZ LIMITED |
Nominee
director |
30/03/2010 |
30/03/2010 |
- |
Active |
NO |
|
8 |
U32200MH1999PLC121164 |
MICROQUAL
TECHNO LIMITED |
Additional
director |
25/11/2010 |
25/11/2010 |
- |
Active |
NO |
|
9 |
U64202DL2003PTC122688 |
VALUEFIRST
MESSAGING PRIVATE LIMITED |
Director |
26/09/2011 |
25/02/2011 |
- |
Active |
NO |
KEY EXECUTIVES
|
Name : |
Mr. K Sunder |
|
Designation : |
Company Secretary |
|
Address : |
1st Floor, |
|
Date of Birth/Age : |
03.06.1960 |
|
Date of Appointment : |
30.06.2011 |
|
Tel No: |
91-44-42815423 |
|
Email: |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on :15.09.2011
|
Names of Shareholders (Equity Shares) |
|
No. of Shares |
|
Dr. GSK Velu |
|
595030 |
|
Mr. Sameer D Saral |
|
100 |
|
Mrs. Suba K Velu |
|
100 |
|
Eplanet Ventures Mauritius Limited, |
|
12850 |
|
Hav2 ( |
|
12850 |
|
|
|
|
|
|
Total
|
620930 |
|
Names of Shareholders (Preference Shares) |
|
No. of Shares |
|
Eplanet Ventures Mauritius Limited, |
|
94725 |
|
Hav2 ( |
|
94725 |
|
|
|
|
|
|
Total
|
189450 |
Equity Shares Breakup (Percentage of Total Equity):
As On : 15.09.2011
|
S.
No. |
Category |
Percentage |
|
1 |
Foreign holdings( Foreign institutional
investor(s), Foreign companie(s) Foreign financial institution(s),
Non-resident Indian(s) or Overseas Corporate bodies or Others |
4.14 |
|
2 |
Directors
or relatives of Directors |
95.86 |
|
|
|
|
|
|
Total |
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturers of
Diagnostic Products |
|
|
|
|
Products : |
v
Immulite
Analyser v
Cell
Counter v
Blood
Gas Analyser v
Celly-Haematology
Analyser v
Others-Spares
and Consumables |
|
|
|
|
Exports to : |
|
|
Products : |
Finished Goods |
|
Country : |
·
·
·
|
|
|
|
|
Imports from : |
|
|
Products : |
Raw Material |
|
Country : |
|
|
|
|
|
Terms : |
|
|
Selling : |
L/C, Cash, Credit
|
|
|
|
|
Purchasing : |
L/C, Cash, Credit |
GENERAL INFORMATION
|
Customers : |
v
Hospital
v
Others
|
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Employees: |
100
(Approximately) |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Bankers: |
· ING Vysya Bank Limited, Address: 13/1, Karpagambal Nagar, Mylapore
Branch, Chennai – 600 004, Tamil Nadu, ·
HDFC Bank Limited Address: Chennai – 600 002, Tamil Nadu, ·
Standard
Chartered Bank, Chennai, ·
ING
Vysya Bank |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Facilities : |
|
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Banking Relations : |
-- |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Auditors : |
BSR and Company Chartered
Accountants |
||||||||||||||||||||||||||||||||||||
|
Address: |
36, New No. 6, |
||||||||||||||||||||||||||||||||||||
|
Tel. No.: |
91-44-24992261/
1347/ 4231 |
||||||||||||||||||||||||||||||||||||
|
Fax No.: |
91-44-24991408 |
||||||||||||||||||||||||||||||||||||
|
Email: |
|||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Subsidiary Company : |
·
Trivitron Dental Technologies Private Limited
(formerly Trivitech Healthcare Private Limited ) (‘TDTPL’) CIN No.: U29297TN2001PTC047581 ·
Trivitron Medical Technologies Private Limited
(‘TMT’) CIN No.: U74140TN1999PTC043339 ·
Trivitron Medical Systems Private Limited (‘TMS’) CIN No.: U33112TN1997PTC037396 |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Associates / Joint Ventures : |
·
Aloka Trivitron Medical Technologies Private
Limited (‘Aloka’) ·
Star Trivitron FZ LLC, ·
Vision Medicaid Equipments Private Limited
(‘Vision’) ·
Biosystems Diagnostics Private Limited (‘BDP’) ·
Trivitron Nawakrama Medical Technologies Private
Limited (’TNM’) ·
·
ET Trivitron Medical Solutions Private Limited
(formerly Biosystems ·
Diagnostics ( |
||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||
|
Others (Enterprises over which key management
personnel are able to exercise control) |
·
Brandon Trivitron Medical Technologies Private
Limited (‘BTM’) ·
Metropolis Healthcare Limited (‘MHL’) ·
Golwilkar Metropolis Health Services ( ·
Desai Metropolis Health Services Private Limited
(‘DMH’) ·
Hexel Healthcare Consulting ( ·
Metropolis Clinical Diagnostics ( ·
Sudharma Metropolis Health Services Private
Limited (‘SMH’) |
||||||||||||||||||||||||||||||||||||
CAPITAL STRUCTURE
(As on
31.03.2011):-
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
850100 |
Equity shares |
Rs. 10/- each |
Rs.8.501 millions |
|
249900 |
Class A Convertible Preference Shares |
Rs.10/- each |
Rs.2.499 Millions |
|
|
|
|
|
|
|
Total |
|
Rs.11.000
Millions |
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
620930 |
Equity shares |
Rs. 10/-
each |
Rs.6.209
millions |
|
189450 |
Class A Convertible Preference Shares |
Rs.10/- each |
Rs.1.894
Millions |
|
|
|
|
|
|
|
Total |
|
Rs.8.103 Millions |
Notes
(A) 850,000 (March
31, 2010: 850,000) equity shares of Rs 10 each 100 (March 31, 2010: 100) Class
'A' equity shares of Rs 10 each
(B) 850,000 (March
31, 2010: 850,000) equity shares of Rs 10 each 100 (March 31, 2010: 100) Class
'A' equity shares of Rs 10 each
(C) 620,830 (March
31, 2010: 620,830) equity shares of Rs 10 each fully paid up 100 (March 31,
2010: 100) Class 'A' equity shares of Rs 10 each fully paid up
(D) 620,830 (March
31, 2010: 620,830) equity shares of Rs 10 each fully paid up 100 (March 31,
2010: 100) Class 'A' equity shares of Rs 10 each fully paid up
(E) 189,450 (March
31, 2010: 189,450) Series 'A' 0.01 % Compulsorily convertible, cumulative
preference shares of Rs 10 each fully paid up
(F) 189,450 (March
31, 2010: 189,450) Series 'A' 0.01 % Compulsorily convertible, cumulative
preference shares of Rs 10 each fully paid up
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
8.103 |
8.103 |
8.103 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
549.697 |
539.429 |
475.579 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
557.800 |
547.532 |
483.682 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
257.954 |
166.046 |
67.721 |
|
|
2] Unsecured Loans |
27.443 |
13.147 |
8.466 |
|
|
TOTAL BORROWING |
285.397 |
179.193 |
76.187 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
843.197 |
726.725 |
559.869 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
116.640 |
108.266 |
105.549 |
|
|
Capital work-in-progress |
0.000 |
7.608 |
6.197 |
|
|
|
|
|
|
|
|
INVESTMENT |
220.624 |
181.079 |
176.486 |
|
|
DEFERREX TAX ASSETS |
3.324 |
0.522 |
2.867 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
523.225
|
220.185 |
179.165 |
|
|
Sundry Debtors |
430.011
|
312.039 |
206.931 |
|
|
Cash & Bank Balances |
99.909
|
74.060 |
77.579 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
140.626
|
181.306 |
142.368 |
|
Total
Current Assets |
1193.771
|
787.590 |
606.043 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
619.583
|
290.294 |
292.556 |
|
|
Other Current Liabilities |
53.486
|
44.322 |
32.451 |
|
|
Provisions |
1.994
|
10.893 |
12.266 |
|
Total
Current Liabilities |
675.063
|
343.509 |
337.273 |
|
|
Net Current Assets |
518.708
|
444.081 |
268.770 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
(16.099) |
(14.831) |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
843.197 |
726.725 |
559.869 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
|
|
SALES |
|
|
|
|
|
|
|
Sales Net |
1388.018 |
1270.160 |
795.824 |
|
|
|
Other Income |
|
23.950 |
27.671 |
|
|
|
TOTAL (A) |
1388.018 |
1294.110 |
823.495 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
Purchase of Traded goods |
|
921.370 |
703.578 |
|
|
|
(Increase) in inventory |
1326.150 |
(39.027) |
(114.049) |
|
|
|
Employee Costs |
|
103.467 |
67.767 |
|
|
|
Operation and other expenses |
|
176.866 |
118.289 |
|
|
|
TOTAL (B) |
1326.150 |
1162.676 |
775.583 |
|
|
|
|
|
|
|
|
Less |
PROFIT
BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C) |
61.868 |
131.434 |
47.912 |
|
|
|
|
|
|
|
|
|
Less |
FINANCIAL
EXPENSES (D) |
28.942 |
21.622 |
10.920 |
|
|
|
|
|
|
|
|
|
|
PROFIT
BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E) |
32.926 |
109.812 |
36.992 |
|
|
|
|
|
|
|
|
|
Less/ Add |
DEPRECIATION/
AMORTISATION (F) |
17.593 |
10.817 |
13.153 |
|
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX (E-F) (G) |
15.333 |
98.995 |
23.839 |
|
|
|
|
|
|
|
|
|
Less |
TAX (H) |
5.021 |
35.102 |
9.692 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
(G-H) (I) |
10.312 |
63.893 |
14.147 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
146.343 |
88.882 |
76.193 |
|
|
|
|
|
|
|
|
|
Less |
APPROPRIATIONS |
|
|
|
|
|
|
|
Transfer to General Reserve |
1.031 |
6.389 |
1.414 |
|
|
|
Dividend |
0.043 |
0.037 |
0.037 |
|
|
|
Tax on Dividend |
0.000 |
0.006 |
0.006 |
|
|
BALANCE CARRIED
TO THE B/S |
155.581 |
146.343 |
88.882 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Commission |
|
5.312 |
19.205 |
|
|
|
Export Sales |
|
15.751 |
8.293 |
|
|
TOTAL EARNINGS |
8.964 |
21.063 |
27.498 |
|
|
|
|
|
|
|
|
|
|
IMPORTS |
|
|
|
|
|
|
|
Equipments, consumables and spares |
1156.586 |
670.961 |
364.077 |
|
|
TOTAL IMPORTS |
1156.586 |
670.691 |
364.077 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
16.61 |
102.90 |
22.70 |
|
The above information has been parted by Ms. Anandi.
KEY RATIOS
|
PARTICULARS |
|
31.03.2011 |
31.03.2010 |
31.03.2009 |
|
PAT / Total Income |
(%) |
0.74
|
4.93 |
1.71 |
|
|
|
|
|
|
|
Net Profit Margin (PBT/Sales) |
(%) |
--
|
7.79 |
3.00 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
1.17
|
11.05 |
3.35 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.02
|
0.18 |
0.04 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
1.72
|
0.95 |
0.85 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.76
|
2.29 |
1.79 |
LOCAL AGENCY FURTHER INFORMATION
|
Check List by Info Agents |
Available in Report (Yes / No) |
|
1. Year of Establishment |
Yes |
|
2. Locality of the firm |
Yes |
|
3. Constructions of the firm |
Yes |
|
4. Premises details |
Yes |
|
5. Type of Business |
Yes |
|
6. Line of Business |
Yes |
|
7. Promoter’s background |
----------- |
|
8. No. of Employees |
Yes |
|
9. Name of person contacted |
Yes |
|
10. Designation of contact person |
Yes |
|
11. Turnover of firm for last three years |
No |
|
12. Profitability for last three years |
No |
|
13. Reasons for variation <> 20% |
No |
|
14. Estimation for coming financial year |
No |
|
15. Capital in the business |
Yes |
|
16. Details of sister concerns |
Yes |
|
17. Major suppliers |
No |
|
18. Major customers |
No |
|
19. Payments terms |
Yes |
|
20. Export / Import details |
Yes |
|
21. Market information |
------- |
|
22. Litigations that the firm / promoter involved |
------ |
|
23. Banking Details |
Yes |
|
24. Banking facility details |
Yes |
|
25. Conduct of the banking account |
------ |
|
26. Buyer visit details |
------ |
|
27. Financials, if provided |
No |
|
28. Incorporation details, if applicable |
------ |
|
29. Last accounts filed at ROC |
------ |
|
30. Major Shareholders, if available |
------ |
COMPANY BACKGROUND
Subject (‘the Company’)
was incorporated on May 18, 1998 in the name and style, Chiron Diagnostics
Limited (CDL) under the provisions of the Companies Act, 1956. On October 23,
2008, the name of the Company was changed to its present name i.e. Trivitron
Healthcare Private Limited. The Company is engaged in the business of trading
of medical equipments, diagnostic reagents, consumables, other healthcare
products and hospital supplies.
BUSINESS OPERATIONS AND FUTURE OUTLOOKFUTURE
OUTLOOK
The Company
started focusing on Innovation, Manufacturing and International operations as
three pillar of its growth. The Company today is the largest Medical Technology
Company of Indian Origin, with more than 12% of revenues coming from
Manufacturing, Services and International Operations. The Company's vision is
to think Out of Box to make the most innovative Medical Technology products
affordable to the larger section of population in the Emerging Markets with
particular focus to
From Nil Manufacturing
revenues two years back, the Company already has over 8% of its revenues coming
out of Manufacturing with Distribution and Services contributing to the rest of
92%.
The Company’s current
key focus areas are three segments namely Lab Diagnostic (In Vitro
Diagnostics), Imaging (In vivo diagnostics) and Cardiology (medical equipment
and devices), and opportunistic areas being Criticare-OR, dental and
ophthalmology.
Strategically, the
Company is well placed to achieve its next growth phase. Their key focus area
which contributes to more than 80% of revenues and profits are Imaging
Diagnostic (In vivo), Lab Diagnostics (IVD) and Cardiology (Equipment and
devices). Other Key areas of focus with solid strategies are Dental and
Ophthalmology.
Through focused approach in manufacturing, innovation, service and
trading, and Company is well poised to achieve excellent growth.
FORM 8:-
|
Corporation identity number or foreign company registrations number of
the company |
U85110TN1998PTC040515 |
|
Name of the company |
TRIVITRON HEALTHCARE PRIVATE LIMITED |
|
Address |
Trivitron Sapthagiri Bhavan, No. 15 Street, Abhiramapuram, Chennai – 600018, Tamilnadu. |
|
This Form is for |
Creation of charge |
|
Type of Charges |
Movable property Book debts Floating charge |
|
Particular of the charge holder
|
HDFC Bank Limited Address: HDFC Bank Houses Senapati Bapat Marg, Email ID: srinivasan.venkatatraman@hdfcbank.com |
|
Nature or description of the instrument creating charge |
i) Letter of Hypothecation of Stocks and Book Debts dated 16th May, 2009; and ii) Memorandum relating to Hypothecation of of Machinery dated 16th May, 2009. |
|
Date of the instrument creating charge |
16.05.2009 |
|
Amount Secure by the charge |
Rs. 125.000 millions |
|
Brief of the principal terms and conditions and extent and operation of
the charge |
Rate of Interests: Any such rate as may be advised to the company from time to time in respect of the credit facilities. Term of repayment: Repayable on Demand Margin: As may be prescribed by the bank from time to time for the credit facilities. Extent and operation of charge: Hypothecation by way of Exclusive First Charge in favour of HDFC Bank Ltd on all all the Stock in trade, Book Debts and all the movable Plant & Machinery of the Company both present and future. |
|
Shorts particulars of the
Property charged |
Hypothecation by way of Exclusive First Charge in favour of HDFC Bank Ltd on all all the Stock in trade, Book Debts and all the movable Plant & Machinery of the Company both present and future |
Fixed Assets:
· Machineries and Equipments,
· Furniture and Fittings,
· Buildings and Interior Decoration,
· Vehicles,
· Computers
· Capital work in progress etc.
CONTINGENT LIABILITIES NOT PROVIDED FOR :
|
Particulars |
Rs. in Millions 31.03.2011 |
|
|
|
|
Counter Gurntee
and commitment in respect of Bank Gurantees and Letters of credit issued by
company’s Bankers |
311.957 |
|
|
|
AS PER WEBSITE DETAILS
Trivitron Healthcare
launches 'Pride' series
Press Trust Of
Chennai-based Trivitron Healthcare today announced the launch of its Pride Series, an array of "innovative" products researched and designed for the Indian health industry.
Dr GSK Velu, Managing Director, Trivitron Medical System, told reporters that
the company has set up a 75,000 sq Ft manufacturing facility near Chennai to
facilitate the design, development and production of the pride series of
products, divided into Cardiac Care, Critical Care and Imaging categories where
the company would manufacture products like Cardiac Monitors, high frequency
X-ray generators and other equipment.
"We are also considering the products from our other Global facilities as
based on our requirement," he said adding the products would cost 30-50
per cent less than other brands operating in this
segment.
|
|
The company had invested Rs 20 crore on pride series, eyeing
a return of Rs 100 crore within a year, he added.
Due to lack of enough government sops for the industry, Velu said it was predominantly import-oriented, with only Rs 2,000 crore worth equipment of the Rs 12,000 crore sized industry being locally produced.
With a view to promoting indigenisation of the industry, the government should come out with Medical Technology Parks of India (MTPI), on the lines of Software Technology Parks of India (STPI) where extensive research and development of medical equipment could take place.
He also recalled his company's various international joint ventures to boost R and D.
Trivitron announces
its Investment in Vision Engineering Private Limited
Trivitron to spend Rs.100 millions to modernize
and expand the facilities of Vision Engineering
CE Certified products to be marketed in Emerging
global markets
Pune, January 13th, 2009 :
Trivitron, the largest medical technology provider of Indian origin has today
announced its investment in Vision Engineering Pvt Ltd, a Pune based X-ray
machine manufacturing company. Post this deal, Trivitron will spend Rs. 10
crore for modernizing and expanding two facilities of Vision Engineering
located at Pune. The X-ray machines manufactured from these facilities have
obtained CE Certification and will be marketed under the brand name “Trivitron Pride Series” in the
emerging global markets like Middle East and
Vision Engineering has been manufacturing X-ray machines on OEM basis for leading MNCs and post this deal, it will continue to do so for other brands too.
Commenting on the investment in Vision Engineering, Dr. G.S.K.
Velu, Managing Director, Trivitron, says “By taking a controlling stake
in Vision Engineering we are expanding our Medical equipment vertical. Vision
Engineering set up in the late sixties has a team of 50 dedicated manpower and
had already installed X-ray equipments over 3000 locations. We are proud that
we have been able to attain CE certification which is necessary
for exports. CE certification has been obtained for all the medical equipments
manufactured at our end including X-ray machines including High
Frequency Xray Generators and C Arm Products of Vision Engineering. We are targeting the
emerging global markets to sell our products under the brand name Trivitron
Pride Series. With the strong R&D team in place we believe that this new
venture will help us expand our national and international operations in the
medical equipment vertical”
Mr. Devendra D Ajingar, Director of Vision Engineering
Private Limited says “We are very proud to be associated with Trivitron which aims to bring
in revolution in the Indian medical manufacturing industry moving forward with
a clear focus on developing capabilities with internal resources and providing
quality and affordable healthcare services to the people. I’m sure with our
presence in the medical equipment manufacturing industry over 30 years; we
would be able to play a major role in supporting Trivitron’s mission to provide
world class services for the Indian health care sector.”
Trivitron will soon be building a new modern, state of the art factory in Pune for housing X Ray, C Arm Manufacturing. They are also initiating R&D to manufacture Portable Cathlab soon in the new facility. The new facility will come up in Pune in the next 15 months.
While Trivitron's Medical Technology Park in Chennai will focus on
manufacturing high end Patented products in JV route, the Pune facility will
focus on manufacturing the Generic Medical Instruments in the name of Trivitron Pride series. Pride Series
will have an array of innovative products specifically designed, developed and
manufactured in-house by Trivitron to suit the requirements of the Indian
healthcare industry. The Trivitron Pride series will come with quality
certification of CE, FDA enabling easy exports of these products into the
European markets. Cardiac monitors, LED warmers, Incubators, High frequency
infant Ventilators, OT instruments, HF X-ray generators, and critical analyzers
will be the products christened under the pride series banner.
About Trivitron
Trivitron is one of the top 10 medical technology companies
in
Their main focus is to help the Indian markets identify their requirements,
provide them a host of international brands & indigenous options to choose
from, and aid them in getting maximum value out of these brands through
excellent service support and continuous medical knowledge initiatives. The key
partners are the top international brands in the industry like Aloka(Japan), Biosystems(Spain), Boston
Scientific Inc(USA), Hamilton(Switzerland),Hologic Inc(USA), Nihon Kohden(Japan),
Gambro(Sweden) - brands synonymous with their fields of specialisation,
worldwide to support quality.
Trivitron is at the forefront of creating a first-of-its-kind, world class
manufacturing facility in
With the unique combination of resources, values and experience, they offer
cutting-edge, turnkey solutions for the healthcare sector.
Trivitron commences
first production at Trivitron Manufacturing facility
Chennai, January 29th, 2009 :
Trivitron Healthcare, the leading medical technology company of Indian origin
is proud to announce production of its first Portable Black and White
ultrasound scanner Aloka SSD 500. This is the first production under Aloka
Trivitron Medical Technologies P Ltd. in its manufacturing facility at
Poonamallee, Chennai. This is a Joint Venture of Trivitron and
Aloka SSD 500 is multipurpose diagnostic ultrasound system providing excellent
image quality with comprehensive function in truly portable body. Aloka SSD 500
is a world premier portable model now being produced in
The core vision of Trivitron Healthcare is to bring world-class medical
technology within the reach of medical professionals all over the world. We
also aim to set up advanced facilities in joint collaboration for the
manufacture of Laboratory reagents for Routine and Special Diagnostics testing
in JV with
The facility will adhere to all international standards such as ISO 9000-2001,
ISO 13485 for medical product manufacturing and will also be compliant with
requirements for
Trivitron partners
with Hologic to serve the healthcare needs of women in
CHENNAI, November 17th, 2008 :
The Trivitron Group of companies, the largest medical technology company of Indian origin, today announced that they have signed an agreement with Hologic, Inc., (NASDAQ: HOLX) a technology leader in women’s health product areas including mammography and breast biopsy, cervical cancer screening, treatment of menorrhagia, osteoporosis assessment, and preterm birth risk assessment.
“Hologic takes enormous pride in the quality of our products
and the opportunity to impact the lives of others,” said Jack Cumming,
Hologic’s Chairman and Chief Executive Officer. “The 4,000 associates of
Hologic and our distribution partners in 125 countries are committed to
improving the health of women around the world. We believe that Trivitron has
the resources and the resolve to help us make a difference for women in
Trivitron is the only company in
Trivitron Healthcare will be the first in the country to make a concerted effort to specifically address the issues of women’s health. Their main focus, initially, will be on the Hologic Reproductive and Gynaecological Surgical Health product lines.
“We are proud of this alliance with Hologic, and happy to
serve the health care needs of the women in
“The women’s health market in
Trivitron is one of the top 10 medical technology companies in
Their main focus is to help the Indian markets identify their requirements,
provide them a host of international brands & indigenous options to choose
from, and aid them in getting maximum value out of these brands through excellent
service support and continuous medical knowledge initiatives. The key partners
are the top international brands in the industry like Aloka, Hamilton, Nihon Kohden - brands
synonymous with their fields of specialisation, worldwide to support quality.
Trivitron is at the forefront of creating a first-of-its-kind, world class
manufacturing facility in
With the unique combination of resources, values and experience, they offer
cutting-edge, turnkey solutions for the healthcare sector.
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No records exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international anti-terrorism
laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or
investigation registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No
available information exist that suggest that subject or any of its principals
have been formally charged or convicted by a competent governmental authority
for any financial crime or under any formal investigation by a competent
government authority for any violation of anti-corruption laws or international
anti-money laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on
Corporate Governance to identify management and governance. These factors often
have been predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs. 50.32 |
|
|
1 |
Rs. 77.96 |
|
Euro |
1 |
Rs. 65.30 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
6 |
|
PAID-UP CAPITAL |
1~10 |
5 |
|
OPERATING SCALE |
1~10 |
6 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
6 |
|
--PROFITABILIRY |
1~10 |
6 |
|
--LIQUIDITY |
1~10 |
6 |
|
--LEVERAGE |
1~10 |
6 |
|
--RESERVES |
1~10 |
6 |
|
--CREDIT LINES |
1~10 |
6 |
|
--MARGINS |
-5~5 |
-- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
YES |
|
--AFFILIATION |
YES/NO |
YES |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
53 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.